Logo image of CARM.PA

CARMILA (CARM.PA) Stock Fundamental Analysis

EPA:CARM - Euronext Paris - Matif - FR0010828137 - REIT - Currency: EUR

16.68  -0.3 (-1.77%)

Fundamental Rating

6

Taking everything into account, CARM scores 6 out of 10 in our fundamental rating. CARM was compared to 41 industry peers in the Diversified REITs industry. CARM scores excellent on profitability, but there are some minor concerns on its financial health. CARM scores decently on growth, while it is valued quite cheap. This could make an interesting combination. These ratings could make CARM a good candidate for value investing.


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

CARM had positive earnings in the past year.
In the past year CARM had a positive cash flow from operations.
Of the past 5 years CARM 4 years were profitable.
In the past 5 years CARM always reported a positive cash flow from operatings.
CARM.PA Yearly Net Income VS EBIT VS OCF VS FCFCARM.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M

1.2 Ratios

CARM's Return On Assets of 4.65% is fine compared to the rest of the industry. CARM outperforms 78.05% of its industry peers.
CARM's Return On Equity of 9.19% is amongst the best of the industry. CARM outperforms 82.93% of its industry peers.
With an excellent Return On Invested Capital value of 4.52%, CARM belongs to the best of the industry, outperforming 85.37% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for CARM is in line with the industry average of 3.55%.
The 3 year average ROIC (3.52%) for CARM is below the current ROIC(4.52%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 4.65%
ROE 9.19%
ROIC 4.52%
ROA(3y)2.69%
ROA(5y)1.6%
ROE(3y)5.18%
ROE(5y)3.03%
ROIC(3y)3.52%
ROIC(5y)3.08%
CARM.PA Yearly ROA, ROE, ROICCARM.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10 15

1.3 Margins

CARM has a better Profit Margin (61.91%) than 73.17% of its industry peers.
CARM's Profit Margin has improved in the last couple of years.
CARM has a Operating Margin of 89.71%. This is amongst the best in the industry. CARM outperforms 87.80% of its industry peers.
CARM's Operating Margin has improved in the last couple of years.
CARM has a Gross Margin of 73.12%. This is comparable to the rest of the industry: CARM outperforms 48.78% of its industry peers.
In the last couple of years the Gross Margin of CARM has remained more or less at the same level.
Industry RankSector Rank
OM 89.71%
PM (TTM) 61.91%
GM 73.12%
OM growth 3Y17.79%
OM growth 5Y7.19%
PM growth 3Y11.44%
PM growth 5Y20.21%
GM growth 3Y2.7%
GM growth 5Y-0.75%
CARM.PA Yearly Profit, Operating, Gross MarginsCARM.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 100 150 200

5

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), CARM is destroying value.
The number of shares outstanding for CARM has been reduced compared to 1 year ago.
CARM has more shares outstanding than it did 5 years ago.
CARM has a better debt/assets ratio than last year.
CARM.PA Yearly Shares OutstandingCARM.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M
CARM.PA Yearly Total Debt VS Total AssetsCARM.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

CARM has an Altman-Z score of 0.96. This is a bad value and indicates that CARM is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of 0.96, CARM perfoms like the industry average, outperforming 58.54% of the companies in the same industry.
The Debt to FCF ratio of CARM is 9.40, which is on the high side as it means it would take CARM, 9.40 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 9.40, CARM is in the better half of the industry, outperforming 78.05% of the companies in the same industry.
CARM has a Debt/Equity ratio of 0.78. This is a neutral value indicating CARM is somewhat dependend on debt financing.
The Debt to Equity ratio of CARM (0.78) is worse than 60.98% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.78
Debt/FCF 9.4
Altman-Z 0.96
ROIC/WACC0.9
WACC5.04%
CARM.PA Yearly LT Debt VS Equity VS FCFCARM.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B

2.3 Liquidity

A Current Ratio of 1.22 indicates that CARM should not have too much problems paying its short term obligations.
CARM has a Current ratio of 1.22. This is amongst the best in the industry. CARM outperforms 80.49% of its industry peers.
CARM has a Quick Ratio of 1.22. This is a normal value and indicates that CARM is financially healthy and should not expect problems in meeting its short term obligations.
CARM's Quick ratio of 1.22 is amongst the best of the industry. CARM outperforms 82.93% of its industry peers.
Industry RankSector Rank
Current Ratio 1.22
Quick Ratio 1.22
CARM.PA Yearly Current Assets VS Current LiabilitesCARM.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

5

3. Growth

3.1 Past

CARM shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 15358.74%, which is quite impressive.
CARM shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 22.86% yearly.
CARM shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 9.72%.
Measured over the past years, CARM shows a small growth in Revenue. The Revenue has been growing by 2.93% on average per year.
EPS 1Y (TTM)15358.74%
EPS 3Y18.46%
EPS 5Y22.86%
EPS Q2Q%815.55%
Revenue 1Y (TTM)9.72%
Revenue growth 3Y5.68%
Revenue growth 5Y2.93%
Sales Q2Q%19.15%

3.2 Future

The Earnings Per Share is expected to grow by 4.66% on average over the next years.
CARM is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.05% yearly.
EPS Next Y6.95%
EPS Next 2Y5.63%
EPS Next 3Y4.66%
EPS Next 5YN/A
Revenue Next Year7.01%
Revenue Next 2Y4.75%
Revenue Next 3Y4.05%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
CARM.PA Yearly Revenue VS EstimatesCARM.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 100M 200M 300M 400M 500M
CARM.PA Yearly EPS VS EstimatesCARM.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0.5 1 1.5

8

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 7.55, the valuation of CARM can be described as very cheap.
87.80% of the companies in the same industry are more expensive than CARM, based on the Price/Earnings ratio.
When comparing the Price/Earnings ratio of CARM to the average of the S&P500 Index (26.31), we can say CARM is valued rather cheaply.
A Price/Forward Earnings ratio of 9.26 indicates a reasonable valuation of CARM.
78.05% of the companies in the same industry are more expensive than CARM, based on the Price/Forward Earnings ratio.
CARM's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 22.13.
Industry RankSector Rank
PE 7.55
Fwd PE 9.26
CARM.PA Price Earnings VS Forward Price EarningsCARM.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CARM indicates a rather cheap valuation: CARM is cheaper than 92.68% of the companies listed in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of CARM indicates a rather cheap valuation: CARM is cheaper than 85.37% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 8.05
EV/EBITDA 10.91
CARM.PA Per share dataCARM.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

CARM's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
The excellent profitability rating of CARM may justify a higher PE ratio.
PEG (NY)1.09
PEG (5Y)0.33
EPS Next 2Y5.63%
EPS Next 3Y4.66%

6

5. Dividend

5.1 Amount

CARM has a Yearly Dividend Yield of 7.36%, which is a nice return.
CARM's Dividend Yield is rather good when compared to the industry average which is at 5.49. CARM pays more dividend than 90.24% of the companies in the same industry.
CARM's Dividend Yield is rather good when compared to the S&P500 average which is at 2.39.
Industry RankSector Rank
Dividend Yield 7.36%

5.2 History

The dividend of CARM decreases each year by -4.29%.
Dividend Growth(5Y)-4.29%
Div Incr Years0
Div Non Decr Years0
CARM.PA Yearly Dividends per shareCARM.PA Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2024 0.2 0.4 0.6 0.8

5.3 Sustainability

54.49% of the earnings are spent on dividend by CARM. This is a bit on the high side, but may be sustainable.
DP54.49%
EPS Next 2Y5.63%
EPS Next 3Y4.66%
CARM.PA Yearly Income VS Free CF VS DividendCARM.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M 300M
CARM.PA Dividend Payout.CARM.PA Dividend Payout, showing the Payout Ratio.CARM.PA Dividend Payout.PayoutRetained Earnings

CARMILA

EPA:CARM (6/13/2025, 7:00:00 PM)

16.68

-0.3 (-1.77%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)04-17 2025-04-17
Earnings (Next)07-23 2025-07-23
Inst Owners29.64%
Inst Owner ChangeN/A
Ins Owners0.04%
Ins Owner ChangeN/A
Market Cap2.36B
Analysts81.33
Price Target20.5 (22.9%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 7.36%
Yearly Dividend1.21
Dividend Growth(5Y)-4.29%
DP54.49%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-0.72%
PT rev (3m)-1.19%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0.55%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-4.25%
Valuation
Industry RankSector Rank
PE 7.55
Fwd PE 9.26
P/S 4.66
P/FCF 8.05
P/OCF 7.97
P/B 0.69
P/tB 0.69
EV/EBITDA 10.91
EPS(TTM)2.21
EY13.25%
EPS(NY)1.8
Fwd EY10.8%
FCF(TTM)2.07
FCFY12.42%
OCF(TTM)2.09
OCFY12.55%
SpS3.58
BVpS24.11
TBVpS24.1
PEG (NY)1.09
PEG (5Y)0.33
Profitability
Industry RankSector Rank
ROA 4.65%
ROE 9.19%
ROCE 7.04%
ROIC 4.52%
ROICexc 4.63%
ROICexgc 4.63%
OM 89.71%
PM (TTM) 61.91%
GM 73.12%
FCFM 57.84%
ROA(3y)2.69%
ROA(5y)1.6%
ROE(3y)5.18%
ROE(5y)3.03%
ROIC(3y)3.52%
ROIC(5y)3.08%
ROICexc(3y)3.79%
ROICexc(5y)3.29%
ROICexgc(3y)3.79%
ROICexgc(5y)3.29%
ROCE(3y)5.48%
ROCE(5y)4.8%
ROICexcg growth 3Y20.72%
ROICexcg growth 5Y9%
ROICexc growth 3Y20.74%
ROICexc growth 5Y9.01%
OM growth 3Y17.79%
OM growth 5Y7.19%
PM growth 3Y11.44%
PM growth 5Y20.21%
GM growth 3Y2.7%
GM growth 5Y-0.75%
F-Score5
Asset Turnover0.08
Health
Industry RankSector Rank
Debt/Equity 0.78
Debt/FCF 9.4
Debt/EBITDA 5.84
Cap/Depr 77.82%
Cap/Sales 0.6%
Interest Coverage 3.75
Cash Conversion 64.59%
Profit Quality 93.43%
Current Ratio 1.22
Quick Ratio 1.22
Altman-Z 0.96
F-Score5
WACC5.04%
ROIC/WACC0.9
Cap/Depr(3y)129.75%
Cap/Depr(5y)102.72%
Cap/Sales(3y)1.8%
Cap/Sales(5y)1.14%
Profit Quality(3y)3321.64%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)15358.74%
EPS 3Y18.46%
EPS 5Y22.86%
EPS Q2Q%815.55%
EPS Next Y6.95%
EPS Next 2Y5.63%
EPS Next 3Y4.66%
EPS Next 5YN/A
Revenue 1Y (TTM)9.72%
Revenue growth 3Y5.68%
Revenue growth 5Y2.93%
Sales Q2Q%19.15%
Revenue Next Year7.01%
Revenue Next 2Y4.75%
Revenue Next 3Y4.05%
Revenue Next 5YN/A
EBIT growth 1Y57.69%
EBIT growth 3Y24.48%
EBIT growth 5Y10.33%
EBIT Next Year6.57%
EBIT Next 3Y4.26%
EBIT Next 5Y4.34%
FCF growth 1Y8.47%
FCF growth 3Y4.44%
FCF growth 5Y0.82%
OCF growth 1Y7.33%
OCF growth 3Y4.74%
OCF growth 5Y1.02%